Switzerland-based Corden Pharma has signed a distributor agreement with Signet Chemical Corporation, an excipient distributing company for their range of synthetic and MPEG-conjugated phospholipids.
Harish Shah, Managing Director, Signet said, “We are gratified to partner with Corden Pharma adding their phospholipid range to our rising product portfolio. This addition will definitely accelerate our strategic objectives to service the pharma industry with this niche application and quality products and we very much look forward to this collaboration.”
“We are pleased to collaborate with a distinguished company like Signet, the paramount excipient distributors in India who not only service their customers with warehousing and distribution, but also provide excellent and timely technical guidance and regulatory support. We are confident that through Signet we will be magnificently reaching out to our prospective customers in India establishing our unique technology products,” said Dr Jurg Burger, Managing Director, Corden Pharma.
Corden Pharma offers cGMP manufacturing of proprietary phospholipids, monoglycerols, diacylglycerols, sphingosines, ceramides and engineered cationic lipids. They are diversified and excel in development and contract manufacturing, formulation and supply chain management. With multiple cGMP compliant facilities across Europe and the US, Corden Pharma is the flexible, efficient, and cost-effective solution for all synthetic phospholipids.
Signet offers a wide range of excipient portfolio. They serve the Indian pharma industry by interpreting customer requests swiftly, reliably and with the highest technical and commercial level while providing the necessary regulatory and quality support required by the industry.
EP News bureau – Mumbai
